Your browser is no longer supported. Please, upgrade your browser.
Settings
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E27.73 EPS (ttm)4.20 Insider Own0.12% Shs Outstand1.77B Perf Week-0.48%
Market Cap207.45B Forward P/E8.35 EPS next Y13.96 Insider Trans-3.89% Shs Float1.77B Perf Month7.48%
Income7.46B PEG6.19 EPS next Q3.71 Inst Own68.40% Short Float0.77% Perf Quarter-2.57%
Sales55.17B P/S3.76 EPS this Y-48.50% Inst Trans-0.38% Short Ratio1.90 Perf Half Y2.92%
Book/sh7.66 P/B15.21 EPS next Y10.11% ROA5.00% Target Price128.32 Perf Year11.81%
Cash/sh6.88 P/C16.94 EPS next 5Y4.48% ROE56.40% 52W Range101.55 - 121.53 Perf YTD8.74%
Dividend5.20 P/FCF16.43 EPS past 5Y-2.80% ROI12.70% 52W High-4.13% Beta0.79
Dividend %4.46% Quick Ratio0.90 Sales past 5Y14.90% Gross Margin67.90% 52W Low14.73% ATR1.88
Employees50000 Current Ratio1.00 Sales Q/Q11.20% Oper. Margin30.10% RSI (14)55.44 Volatility1.88% 1.57%
OptionableYes Debt/Eq5.96 EPS Q/Q37.60% Profit Margin13.50% Rel Volume0.69 Prev Close118.66
ShortableYes LT Debt/Eq5.46 EarningsOct 29 BMO Payout120.40% Avg Volume7.16M Price116.51
Recom2.00 SMA200.15% SMA504.39% SMA2003.91% Volume4,976,564 Change-1.81%
Nov-23-21Upgrade Societe Generale Hold → Buy $172
Jul-27-21Resumed Truist Buy $118
Apr-07-21Resumed RBC Capital Mkts Outperform $135
Nov-10-20Resumed Bernstein Outperform $120
Sep-29-20Initiated Berenberg Hold $98
Jun-23-20Upgrade Atlantic Equities Neutral → Overweight $115
Jun-09-20Upgrade Wolfe Research Peer Perform → Outperform
Jun-02-20Upgrade Argus Hold → Buy $115
May-18-20Resumed BofA/Merrill Neutral $95
May-12-20Upgrade JP Morgan Neutral → Overweight $105
May-11-20Resumed Morgan Stanley Overweight $95
Apr-20-20Upgrade RBC Capital Mkts Sector Perform → Outperform $79 → $93
Mar-23-20Downgrade Societe Generale Buy → Hold
Feb-27-20Initiated Barclays Equal Weight $97
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Sector Perform $86
Dec-26-19Reiterated Cowen Outperform $90 → $98
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Nov-26-21 12:42PM  
Nov-25-21 12:34PM  
Nov-23-21 11:08AM  
08:15AM  
08:00AM  
07:32AM  
Nov-22-21 06:09AM  
Nov-21-21 08:00AM  
05:52AM  
Nov-20-21 09:03AM  
Nov-19-21 07:45PM  
09:32AM  
08:00AM  
Nov-18-21 01:36PM  
01:04PM  
10:24AM  
09:00AM  
08:45AM  
07:55AM  
07:01AM  
Nov-17-21 10:59AM  
07:50AM  
05:55AM  
02:05AM  
Nov-16-21 07:04AM  
07:00AM  
Nov-15-21 05:24PM  
10:00AM  
08:30AM  
06:01AM  
Nov-14-21 05:55AM  
Nov-12-21 12:30PM  
Nov-10-21 08:30AM  
08:00AM  
Nov-09-21 08:45AM  
08:31AM  
Nov-08-21 08:30AM  
07:24AM  
07:15AM  
Nov-07-21 05:52AM  
Nov-05-21 08:36PM  
02:58PM  
10:35AM  
10:06AM  
03:30AM  
Nov-04-21 09:05AM  
Nov-03-21 10:33AM  
09:08AM  
07:02AM  
Nov-02-21 11:29AM  
Nov-01-21 10:28PM  
09:37AM  
08:31AM  
12:55AM  
Oct-31-21 11:20AM  
Oct-29-21 05:31PM  
04:13PM  
03:31PM  
01:46PM  
12:44PM  
12:03PM  
11:06AM  
10:41AM  
10:28AM  
09:45AM  
09:33AM  
09:24AM  
09:18AM  
09:05AM  
08:09AM  
08:04AM  
07:50AM  
07:43AM  
07:40AM  
07:40AM  
05:57AM  
04:49AM  
Oct-28-21 12:46PM  
10:30AM  
08:15AM  
Oct-27-21 11:15AM  
11:10AM  
07:52AM  
05:52AM  
Oct-26-21 11:00AM  
10:20AM  
08:30AM  
Oct-25-21 06:37PM  
05:45PM  
08:07AM  
06:39AM  
Oct-24-21 04:13AM  
Oct-23-21 10:26AM  
Oct-22-21 03:00PM  
10:08AM  
04:30AM  
Oct-20-21 12:35PM  
Oct-19-21 03:10PM  
12:31PM  
06:10AM  
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AUSTIN ROXANNE SDirectorNov 03Sale117.2320,0002,344,60049,284Nov 04 05:35 PM
AUSTIN ROXANNE SDirectorNov 02Sale116.3851,8446,033,38469,284Nov 04 05:35 PM
Sorg Elaine K.SVP, US Commercial OperationsAug 23Option Exercise114.367,080809,66918,675Aug 25 06:08 PM
Sorg Elaine K.SVP, US Commercial OperationsAug 23Sale120.0013,0801,569,60011,595Aug 25 06:08 PM
Strom Carrie CSVP & Pres Global Allerg AesthAug 23Sale120.005,057606,84051,047Aug 25 06:08 PM
SALEKI-GERHARDT AZITAEVP, OperationsMay 24Option Exercise34.9386,9203,036,230203,204May 26 05:20 PM
SALEKI-GERHARDT AZITAEVP, OperationsMay 24Sale116.2986,92010,108,033116,284May 26 05:20 PM
Strom Carrie CSVP & Pres Global Allerg AesthMay 03Option Exercise41.394,184173,17663,409May 05 04:23 PM
Strom Carrie CSVP & Pres Global Allerg AesthMay 03Sale112.404,184470,28259,225May 05 04:23 PM
GONZALEZ RICHARD AChairman of the Board and CEOMar 02Option Exercise54.86170,1139,332,399546,710Mar 02 08:27 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerMar 01Sale108.5919,5142,119,0410Mar 02 08:31 PM
Sorg Elaine K.SVP, US Commercial OperationsMar 01Sale108.618,440916,64217,595Mar 02 08:30 PM
GONZALEZ RICHARD AChairman of the Board and CEOMar 01Sale108.61170,11318,476,204376,597Mar 02 08:27 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsMar 01Sale108.5913,7731,495,57650,969Mar 02 08:26 PM
Sorg Elaine K.SVP, US Commercial OperationsFeb 22Option Exercise89.7820,1951,813,05252,946Feb 24 06:28 PM
Sorg Elaine K.SVP, US Commercial OperationsFeb 22Sale104.7220,1952,114,73232,751Feb 24 06:28 PM
Stewart Jeffrey RyanEVP, Commercial OperationsDec 29Option Exercise51.4225,2901,300,41276,259Dec 31 01:15 PM
Stewart Jeffrey RyanEVP, Commercial OperationsDec 29Sale105.0025,2902,655,45050,969Dec 31 01:15 PM